| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOPHA.2003.11.003 |
| P698 | PubMed publication ID | 14739059 |
| P2093 | author name string | Angelo Carpi | |
| Angiolo Gadducci | |||
| Andrea Nicolini | |||
| Andrea Riccardo Genazzani | |||
| Stefania Cosio | |||
| P2860 | cites work | Colorectal carcinoma antigens detected by hybridoma antibodies | Q39592186 |
| P433 | issue | 1 | |
| P921 | main subject | cervix uterine cancer | Q160105 |
| P304 | page(s) | 24-38 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Biomedicine and Pharmacotherapy | Q15759648 |
| P1476 | title | Serum tumor markers in the management of ovarian, endometrial and cervical cancer | |
| P478 | volume | 58 |
| Q41395692 | A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass |
| Q39130988 | A study of ovarian cancer biomarker amplification using ultrasound for early stage detection |
| Q36337239 | An Evaluation of the Applicability of the Risk of Malignancy Index for Adnexal Masses to Patients Seen at a Tertiary Hospital in Chandigarh, India |
| Q24170226 | CA125 expression in spontaneous ovarian adenocarcinomas from laying hens |
| Q26823666 | Cancer of unknown primary sites: what radiologists need to know and what oncologists want to know |
| Q58798374 | Clinical Value of Combining F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma |
| Q34991512 | Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA-125) in carcinoma of the endometrium |
| Q33813724 | Development of a multimarker assay for early detection of ovarian cancer |
| Q37422666 | Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin |
| Q64060889 | Diagnostic accuracy and prognostic applications of CYFRA 21-1 in head and neck cancer: A systematic review and meta-analysis |
| Q34857343 | Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review |
| Q38089759 | Endometrial cancer: multiplexed Luminex approaches for early detection |
| Q34665749 | Esophageal cancer management: preoperative CA19.9 and CEA serum levels may identify occult advanced adenocarcinoma |
| Q53468294 | Evaluation of serum CA-125 levels for preoperative counseling in endometrioid endometrial cancer: a multi-center study. |
| Q40361610 | Evolving role of serum biomarkers in the management of ovarian cancer |
| Q58706435 | Exploring prognostic genes in ovarian cancer stage-related coexpression network modules |
| Q51753225 | Expression of high-abundance proteins in sera of patients with endometrial and cervical cancers: analysis using 2-DE with silver staining and lectin detection methods. |
| Q35177014 | Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas |
| Q34611530 | HE4 as a biomarker for ovarian and endometrial cancer management |
| Q56836325 | Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome |
| Q33503713 | Identification of potential serum markers for endometrial cancer using protein expression profiling |
| Q36904006 | Identifying cancer biomarkers by mass spectrometry-based glycomics |
| Q90165841 | Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas |
| Q34142484 | Lung Cancer Serum Biomarker Discovery Using Glycoprotein Capture and Liquid Chromatography Mass Spectrometry |
| Q33560967 | Major clinical research advances in gynecologic cancer 2009. |
| Q46788590 | Management of endometrial cancer |
| Q47357080 | Metastatic mucinous adenocarcinoma of the ovary is characterized by advanced patient age, small tumor size, and elevated serum CA125. |
| Q36848899 | Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front |
| Q35787762 | Mucin 16 is a functional selectin ligand on pancreatic cancer cells |
| Q33732475 | N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin |
| Q91906502 | New serum biomarker identification and analysis by mass spectrometry in cervical precancerous lesion and acute cervicitis in South China |
| Q35204881 | Oncolytic adenovirus co-expressing IL-12 and IL-18 improves tumor-specific immunity via differentiation of T cells expressing IL-12Rβ2 or IL-18Rα. |
| Q37709052 | Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy |
| Q36981396 | Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity |
| Q24632541 | Peripheral biomarkers of endometriosis: a systematic review |
| Q84170389 | Plasma calprotectin concentrations in women with endometrial carcinoma |
| Q98386514 | Prognostic values of CEA, CA19-9, and CA72-4 in patients with stages I-III colorectal cancer |
| Q33245203 | Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment |
| Q61450087 | Proteomic Screening for Serum Biomarkers for Cervical Cancer and Their Clinical Significance |
| Q33360168 | Proteomic studies of early-stage and advanced ovarian cancer patients |
| Q37848725 | Reactive lymphoid hyperplasia of liver mimicking late ovarian cancer recurrence: case report and literature review |
| Q37449241 | Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix |
| Q86928542 | Serum Sialyl-Tn (STN) as a Tumor Marker in Patients with Endometrial Cancer |
| Q37328423 | Serum biomarkers for early detection of gynecologic cancers |
| Q37367905 | Serum carcinoembryonic antigen as a tumour marker in patients with endometrial cancer |
| Q33577443 | Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis |
| Q81736093 | Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma |
| Q39459281 | Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF. |
| Q34062135 | Surgical management of early endometrial cancer: an update and proposal of a therapeutic algorithm |
| Q82359485 | Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts |
| Q36996525 | The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors |
| Q34363510 | The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review |
| Q37789033 | Tumor markers for early detection of ovarian cancer |
| Q36171158 | Two cases of miliary tuberculosis and elevated levels of cancer antigen 125 |
| Q38667018 | microRNA and Ovarian Cancer |
Search more.